Logiscreen

Bio-Techne Corp

$51.99
Market Cap 8.13B
ROE 5.5%
Gross Margin 66.9%
Debt/Equity 0.1
Current Ratio 4.5
Revenue QoQ -1.5%
EPS QoQ 1.4%
F-Score 7

About

Contact: David Clair, Senior Director, Corporate Development [email protected] 612-656-4416 SOURCE Bio-Techne Corporation Related Links https://www.bio-techne.com/

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Overvalued

Trading at a discount to sector peers

P/E
75.94
vs median 31.50
P/B
3.99
vs median 2.17
ROE
0.05
vs median 0.09

High quality company with strong fundamentals

Mid-cap company with growth potential

Similar companies

BPMCABVXHALOCORTCYTKKRYS
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics